{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:30:13Z","timestamp":1773707413032,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brain Tumour Foundation of Canada"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Primary central nervous system (CNS) tumours are heterogeneous, with different treatment pathways and prognoses depending on their histological and molecular classification. Due to their anatomical location, all CNS tumours, regardless of malignancy, can be debilitating. We used vital statistics linked to Canadian Cancer Registry data to estimate the age-standardized incidence rates (ASIR), Kaplan\u2013Meier survival rates (SR), and limited-duration prevalence proportions (PP) of 25 histology-specific CNS tumour groups that were classified based on site and histology. During 2010\u20132017, 45,115 patients were diagnosed with 47,085 primary CNS tumours, of which 19.0% were unclassified. The average annual ASIR was 21.48\/100,000 person-years and did not vary by sex. The ASIR increased with age, particularly for meningioma, unclassified tumours, and glioblastoma. The eight-year PP was 102.1\/100,000 persons (index date 1 January 2018). The most common histology was meningioma (ASIR: 5.19; PP: 31.6). The overall five-year SR among 51,310 patients diagnosed during 2008\u20132017 was 57.2% (95% CI: 56.8\u201357.7%). SRs varied by tumour behaviour, histology, and patient age, with the lowest SR among glioblastoma patients (5-year SRs ranged from 1.3\u201325.7%). For non-malignant tumours, the 5-year SRs ranged from 37.4\u2013100%. We provide the most up-to-date histology-specific surveillance estimates for primary CNS tumours in Canada.<\/jats:p>","DOI":"10.3390\/curroncol30040329","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T04:53:59Z","timestamp":1681966439000},"page":"4311-4328","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Incidence and Prevalence of Primary Central Nervous System (CNS) Tumours in Canada (2010\u20132017), and the Survival of Patients Diagnosed with CNS Tumours (2008\u20132017)"],"prefix":"10.3390","volume":"30","author":[{"given":"Emily V.","family":"Walker","sequence":"first","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"},{"name":"Precision Analytics, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services, Edmonton, AB T5J 3C6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiling","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4961-237X","authenticated-orcid":false,"given":"Seth A.","family":"Climans","sequence":"additional","affiliation":[{"name":"Department of Oncology, Western University, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith G.","family":"Davis","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-9924","authenticated-orcid":false,"given":"Yan","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Alberta, Edmonton, AB T6G 1C9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"ref_1","unstructured":"National Cancer Institute: Surveillance, Epidemiology and End Results Program (2022, December 19). The 2007 Multiple Primary and Histology Coding Rules, Available online: https:\/\/seer.cancer.gov\/tools\/mphrules\/2007_mphrules_manual_08242012.pdf."},{"key":"ref_2","unstructured":"National Cancer Institute: Surveillance, Epidemiology and End Results Program (2022, December 19). Solid Tumour Rules, Available online: https:\/\/seer.cancer.gov\/tools\/solidtumor\/2023\/STM_Combined.pdf."},{"key":"ref_3","unstructured":"Eckstrand, A.C. (2018). CNS Tumours: Exploring Barriers to Registration and Feasibility of Extracting Molecular Characteristics. [Master\u2019s Thesis, University of Alberta]."},{"key":"ref_4","first-page":"10","article-title":"Progress in Net Cancer Survival in Canada over 20 Years","volume":"29","author":"Ellison","year":"2018","journal-title":"Health Rep."},{"key":"ref_5","first-page":"139","article-title":"Current Status of Brain Tumor Surveillance in Canada and Why It Matters","volume":"42","author":"Davis","year":"2015","journal-title":"J. Registry. Manag."},{"key":"ref_6","unstructured":"Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada (2022, December 19). Canadian Cancer Statistics 2021. Available online: https:\/\/cdn.cancer.ca\/-\/media\/files\/research\/cancer-statistics\/2021-statistics\/2021-pdf-en-final.pdf."},{"key":"ref_7","unstructured":"Walker, E.V., Zakaria, D., Yuan, Y., Yasmin, F., Shaw, A., and Davis, F.G. (2022, December 19). Brain Tumour Registry of Canada (BTRC): Incidence (2013\u20132017) and Mortality (2014\u20132018) Report. Available online: https:\/\/braintumourregistry.ca\/wp-content\/uploads\/2021\/05\/FINAL-Incidence-and-Mortality-Report-2021-logo-word-removed.pdf."},{"key":"ref_8","unstructured":"Walker, E.V., Liu, J., Davis, F.G., Climans, S., and Yuan, Y. (2022, December 19). Brain Tumour Registry of Canada (BTRC): Survival Report 2010\u20132017. Available online: https:\/\/braintumourregistry.ca\/wp-content\/uploads\/2022\/06\/Brain-Tumour-Registry-of-Canada-Final-Survival-and-Prevalence-Report-June-2022.pdf."},{"key":"ref_9","unstructured":"(2022, December 19). Journals No. 110\u2014February 14, 2007 (39-1)\u2014House of Commons of Canada. Available online: https:\/\/www.ourcommons.ca\/DocumentViewer\/en\/39-1\/house\/sitting-110\/journals#DOC--2699530."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/nop\/npac089","article-title":"Incidence and survival of primary central nervous system tumors diagnosed in 4 Canadian provinces from 2010 to 2015","volume":"10","author":"Walker","year":"2022","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_11","unstructured":"Government of Canada, S.C. (2022, December 19). Canadian Cancer Registry (CCR). Available online: https:\/\/www23.statcan.gc.ca\/imdb\/p2SV.pl?Function=getSurvey&SDDS=3207&Item_Id=1633&lang=en."},{"key":"ref_12","unstructured":"International Association of Cancer Registries (2022, December 19). International Classification of Diseases for Oncology, Third Edition (ICDO-3). Available online: http:\/\/www.iacr.com.fr\/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Louis, D.N., Ohgaki, H., Wiestler, O.D., and Cavenee, W.K. (2007). WHO Classification of Tumours of the Central Nervous System.","DOI":"10.1007\/s00401-007-0278-6"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"vdaa175","DOI":"10.1093\/noajnl\/vdaa175","article-title":"An Updated Histology Recode for the Analysis of Primary Malignant and Nonmalignant Brain and Other Central Nervous System Tumors in the Surveillance, Epidemiology, and End Results Program","volume":"3","author":"Forjaz","year":"2020","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nagamine, C.M.L., de Goulart, B.N.G., and Ziegelmann, P.K. (2022). Net Survival in Survival Analyses for Patients with Cancer: A Scoping Review. Cancers, 14.","DOI":"10.3390\/cancers14143304"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On Estimation in Relative Survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"key":"ref_17","unstructured":"National Cancer Institute: Surveillance, Epidemiology and End Results Program (2022, December 19). Hematopoietic Project, Available online: https:\/\/seer.cancer.gov\/tools\/heme\/."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro. Oncol."},{"key":"ref_19","first-page":"167","article-title":"On Capturing Radiological Diagnoses of Brain Tumours To Provide Complete Population Data in Cancer Registries in Canada","volume":"45","author":"Yuan","year":"2018","journal-title":"J. Registry. Manag."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1474-4422(18)30468-X","article-title":"Global, Regional, and National Burden of Brain and Other CNS Cancer, 1990\u20132016: A Systematic Analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Patel","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/0284186X.2019.1603396","article-title":"Incidence Trends of Adult Malignant Brain Tumors in Finland, 1990\u20132016","volume":"58","author":"Natukka","year":"2019","journal-title":"Acta Oncologica."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.ejca.2015.07.032","article-title":"Survival of Adults with Primary Malignant Brain Tumours in Europe; Results of the EUROCARE-5 Study","volume":"51","author":"Visser","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ejca.2014.12.014","article-title":"Glioblastoma in England: 2007\u20132011","volume":"51","author":"Brodbelt","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/neuonc\/noac176","article-title":"The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries","volume":"24","author":"Hoogendijk","year":"2022","journal-title":"Neuro. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/4\/329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:19:36Z","timestamp":1760123976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/4\/329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["curroncol30040329"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30040329","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]}}}